vs

Side-by-side financial comparison of PLAYSTUDIOS, Inc. (MYPS) and SI-BONE, Inc. (SIBN). Click either name above to swap in a different company.

SI-BONE, Inc. is the larger business by last-quarter revenue ($56.3M vs $55.4M, roughly 1.0× PLAYSTUDIOS, Inc.). SI-BONE, Inc. runs the higher net margin — -2.9% vs -24.7%, a 21.8% gap on every dollar of revenue. On growth, SI-BONE, Inc. posted the faster year-over-year revenue change (15.0% vs -18.3%). PLAYSTUDIOS, Inc. produced more free cash flow last quarter ($3.6M vs $440.0K). Over the past eight quarters, SI-BONE, Inc.'s revenue compounded faster (22.0% CAGR vs -15.6%).

PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.

Bone Clones, Inc. manufactures, distributes, and sells osteological reproductions of human and animal bones. Located in Chatsworth, California, Bone Clones provides these reproductions to museums, universities, medical schools, and other educational institutions.

MYPS vs SIBN — Head-to-Head

Bigger by revenue
SIBN
SIBN
1.0× larger
SIBN
$56.3M
$55.4M
MYPS
Growing faster (revenue YoY)
SIBN
SIBN
+33.3% gap
SIBN
15.0%
-18.3%
MYPS
Higher net margin
SIBN
SIBN
21.8% more per $
SIBN
-2.9%
-24.7%
MYPS
More free cash flow
MYPS
MYPS
$3.2M more FCF
MYPS
$3.6M
$440.0K
SIBN
Faster 2-yr revenue CAGR
SIBN
SIBN
Annualised
SIBN
22.0%
-15.6%
MYPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MYPS
MYPS
SIBN
SIBN
Revenue
$55.4M
$56.3M
Net Profit
$-13.7M
$-1.6M
Gross Margin
79.0%
Operating Margin
-17.7%
-4.4%
Net Margin
-24.7%
-2.9%
Revenue YoY
-18.3%
15.0%
Net Profit YoY
38.9%
63.4%
EPS (diluted)
$-0.12
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYPS
MYPS
SIBN
SIBN
Q4 25
$55.4M
$56.3M
Q3 25
$57.6M
$48.7M
Q2 25
$59.3M
$48.6M
Q1 25
$62.7M
$47.3M
Q4 24
$67.8M
$49.0M
Q3 24
$71.2M
$40.3M
Q2 24
$72.6M
$40.0M
Q1 24
$77.8M
$37.9M
Net Profit
MYPS
MYPS
SIBN
SIBN
Q4 25
$-13.7M
$-1.6M
Q3 25
$-9.1M
$-4.6M
Q2 25
$-2.9M
$-6.2M
Q1 25
$-2.9M
$-6.5M
Q4 24
$-22.4M
$-4.5M
Q3 24
$-3.1M
$-6.6M
Q2 24
$-2.6M
$-8.9M
Q1 24
$-567.0K
$-10.9M
Gross Margin
MYPS
MYPS
SIBN
SIBN
Q4 25
79.0%
Q3 25
79.8%
Q2 25
79.8%
Q1 25
79.7%
Q4 24
79.1%
Q3 24
79.1%
Q2 24
79.0%
Q1 24
78.9%
Operating Margin
MYPS
MYPS
SIBN
SIBN
Q4 25
-17.7%
-4.4%
Q3 25
-13.6%
-11.1%
Q2 25
-5.9%
-14.4%
Q1 25
-4.4%
-15.8%
Q4 24
-33.1%
-11.2%
Q3 24
-6.7%
-18.9%
Q2 24
-5.5%
-25.2%
Q1 24
-2.2%
-31.8%
Net Margin
MYPS
MYPS
SIBN
SIBN
Q4 25
-24.7%
-2.9%
Q3 25
-15.8%
-9.4%
Q2 25
-5.0%
-12.7%
Q1 25
-4.6%
-13.8%
Q4 24
-33.1%
-9.2%
Q3 24
-4.3%
-16.3%
Q2 24
-3.6%
-22.4%
Q1 24
-0.7%
-28.8%
EPS (diluted)
MYPS
MYPS
SIBN
SIBN
Q4 25
$-0.12
$-0.04
Q3 25
$-0.07
$-0.11
Q2 25
$-0.02
$-0.14
Q1 25
$-0.02
$-0.15
Q4 24
$-0.18
$-0.10
Q3 24
$-0.02
$-0.16
Q2 24
$-0.02
$-0.22
Q1 24
$0.00
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYPS
MYPS
SIBN
SIBN
Cash + ST InvestmentsLiquidity on hand
$104.9M
$42.2M
Total DebtLower is stronger
$35.6M
Stockholders' EquityBook value
$227.9M
$177.5M
Total Assets
$290.6M
$238.6M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYPS
MYPS
SIBN
SIBN
Q4 25
$104.9M
$42.2M
Q3 25
$106.3M
$26.5M
Q2 25
$112.9M
$34.1M
Q1 25
$107.1M
$41.2M
Q4 24
$109.2M
$34.9M
Q3 24
$105.2M
$30.2M
Q2 24
$106.3M
$25.6M
Q1 24
$127.0M
$32.0M
Total Debt
MYPS
MYPS
SIBN
SIBN
Q4 25
$35.6M
Q3 25
$35.5M
Q2 25
$35.5M
Q1 25
$35.5M
Q4 24
$35.5M
Q3 24
$36.2M
Q2 24
$36.1M
Q1 24
$36.1M
Stockholders' Equity
MYPS
MYPS
SIBN
SIBN
Q4 25
$227.9M
$177.5M
Q3 25
$238.9M
$172.1M
Q2 25
$245.3M
$170.3M
Q1 25
$244.1M
$167.3M
Q4 24
$244.7M
$167.0M
Q3 24
$265.2M
$165.0M
Q2 24
$263.6M
$164.7M
Q1 24
$288.4M
$165.5M
Total Assets
MYPS
MYPS
SIBN
SIBN
Q4 25
$290.6M
$238.6M
Q3 25
$299.2M
$234.3M
Q2 25
$316.2M
$230.9M
Q1 25
$313.8M
$227.3M
Q4 24
$323.0M
$230.4M
Q3 24
$330.6M
$227.0M
Q2 24
$333.4M
$223.8M
Q1 24
$357.5M
$223.7M
Debt / Equity
MYPS
MYPS
SIBN
SIBN
Q4 25
0.20×
Q3 25
0.21×
Q2 25
0.21×
Q1 25
0.21×
Q4 24
0.21×
Q3 24
0.22×
Q2 24
0.22×
Q1 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYPS
MYPS
SIBN
SIBN
Operating Cash FlowLast quarter
$3.7M
$1.7M
Free Cash FlowOCF − Capex
$3.6M
$440.0K
FCF MarginFCF / Revenue
6.5%
0.8%
Capex IntensityCapex / Revenue
0.2%
2.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$25.4M
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYPS
MYPS
SIBN
SIBN
Q4 25
$3.7M
$1.7M
Q3 25
$5.7M
$2.3M
Q2 25
$13.6M
$173.0K
Q1 25
$3.3M
$-4.9M
Q4 24
$11.6M
$1.2M
Q3 24
$14.6M
$302.0K
Q2 24
$14.5M
$-6.3M
Q1 24
$5.0M
$-7.6M
Free Cash Flow
MYPS
MYPS
SIBN
SIBN
Q4 25
$3.6M
$440.0K
Q3 25
$5.4M
$-620.0K
Q2 25
$13.2M
$-1.9M
Q1 25
$3.2M
$-7.0M
Q4 24
$11.5M
$-1.1M
Q3 24
$13.9M
$-2.7M
Q2 24
$12.8M
$-9.4M
Q1 24
$3.6M
$-9.7M
FCF Margin
MYPS
MYPS
SIBN
SIBN
Q4 25
6.5%
0.8%
Q3 25
9.3%
-1.3%
Q2 25
22.3%
-4.0%
Q1 25
5.1%
-14.8%
Q4 24
16.9%
-2.2%
Q3 24
19.6%
-6.8%
Q2 24
17.6%
-23.6%
Q1 24
4.6%
-25.5%
Capex Intensity
MYPS
MYPS
SIBN
SIBN
Q4 25
0.2%
2.3%
Q3 25
0.5%
6.1%
Q2 25
0.7%
4.3%
Q1 25
0.2%
4.4%
Q4 24
0.2%
4.6%
Q3 24
0.9%
7.5%
Q2 24
2.4%
7.8%
Q1 24
1.9%
5.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MYPS
MYPS

Segment breakdown not available.

SIBN
SIBN

US$53.5M95%
Non Us$2.9M5%

Related Comparisons